Amazon Pharmacy (AMZN) is expanding access to Novo Nordisk’s (NVO) Ozempic pill, the only FDA-approved oral GLP-1 medication to treat type 2 diabetes. Amazon Pharmacy will offer Same-Day prescription delivery and pickup within minutes through in-office kiosk locations soon, addressing a critical access gap for the more than 36 million Americans living with type 2 diabetes.
Claim 55% Off TipRanks
New trading tool for AMZN bullsPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMZN:
- Nvidia (NVDA) Stock Forecast — 3 Risks Investors Should Watch Closely in 2026
- Amazon (AMZN) Targets GLP-1 Growth with Novo’s Ozempic Pill
- Former OpenAI CTO Spills the Beans – Sam Altman “Created Chaos” and Misled Executives
- Microsoft’s (MSFT) AI Data Center Push Puts Its 2030 Clean Energy Goal at Risk
- Snowflake (SNOW) Grew Fast, Then Slowed Down. Can AI Get It Back on Track?